Early intervention with a highly effective disease-modifying therapy reduces disability progression in relapsing-remitting MS. A comparison of two national cohorts with different treatment strategies showed starting with a more effective therapy was superior to commencing a conventional first-line DMT and escalation. The study, published in JAMA Neurology, compared disability outcomes in Swedish and Danish MS ...
Early treatment with effective DMT holds off RRMS progression
By Mardi Chapman
17 Aug 2021